investordatabase.org

Symbiotics

symbioticsgroup.com Direct + LP

Symbiotics is a market access platform for impact investing focused on private markets in emerging and frontier economies. It provides investment, asset management and capacity building services, and manages an aggregate portfolio of USD 2.5 billion across 19 funds and mandates.

Symbiotics is an asset manager. It invests both directly in companies and in funds as a limited partner, in financial inclusion, climate, fintech and agriculture. USD 2.5 billion under management and 669 portfolio companies, as it reports.

“Symbiotics is the leading market access platform for impact investing, dedicated to private markets in emerging and frontier economies.”

— Symbiotics, own website
Layer
Direct + LP
Type
Asset manager
Stage
Not stated
Invests in
emerging markets, frontier markets
Sectors
financial inclusion, climate, fintech, agriculture
Assets under management
USD 2.5 billion
Portfolio
669 companies

Team, as Symbiotics publishes it

  • Daniel Schriber CEO of Symbiotics Asset Management
  • Arushi Wanchoo Kaul Senior Portfolio Manager, Emerging Credit Fund
  • Samy Derradji Head of Corporate Communication

Names and roles exactly as listed on symbioticsgroup.com. Nothing else about these people is recorded.

Where this comes from

Every fact above was read from a page Symbiotics publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.

Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.

Record 10138 · added 2026-09-29 · link last verified 2026-09-29 · confidence high

Similar investors

Listed under